High-Intensity Interval Training and Performance

Sponsor
Kennesaw State University (Other)
Overall Status
Completed
CT.gov ID
NCT05821504
Collaborator
(none)
30
1
2
3.7
8.2

Study Details

Study Description

Brief Summary

The goal of this clinical trial was to compare to different types of high-intensity interval training in young, healthy females. The main questions were: Will changes in body composition differ between the two interventions? Will changes in endurance and muscle performance differ between the two interventions? Participants were randomized to 8 weeks of high-intensity interval training involving body weight, plyometric exercises or cycling only. Researchers compared changes in endurance performance, body composition, and muscle performance to determine if there were differences between groups.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: High-Intensity Interval Training
N/A

Detailed Description

The purpose of this study was to compare the effects of plyometric- and cycle-oriented high-intensity interval training on body composition, aerobic capacity, and skeletal muscle size, quality, and function in recreationally trained females. Young (21.7 ± 3.1 yrs), recreationally active females were randomly assigned to 8 weeks of twice weekly plyometric (n = 15) or cycling (n = 15) high-intensity interval training. The plyometric-oriented Les Mills BODYATTACK program was used for the plyometric group whereas Les Mills SPRINT, which exclusively involves stationary cycling, represented the cycling group. Both protocols involved alternating high-intensity and recovery intervals, and participants were consistently instructed to give maximal effort during the 'work' periods.

The 30 min plyometric routines included four blocks of high-intensity exercise intervals. The 'work' portions consisted of the following exercises: high-knee runs, plyometric lunges, jumping jacks, squat jumps, burpees, and speed-agility patterns. The recovery periods consisted of complete rest (transitioning between exercises), a light jog, or a low impact stepping motion. On average, participants were instructed to give maximal effort for 1-2 min, with recovery intervals of 15-45 sec. Four separate routines were used throughout the duration of the study, keeping one routine per week; participants completed each routine a total of 4 times within a session.

The 30 min cycling routines were performed on upright stationary bikes (Schwinn, AC Performance, Chicago, IL). Protocols involved 'work' ranging from 20-80 sec with recovery intervals between 10-60 sec. Recovery intervals consisted of complete rest on bike or particularly slow cycling. Resistance and cycling speed were relatively variable across sessions, with some intervals of higher resistance and lower speed and others involving lower resistance and higher speed (e.g., >120 RPMs). The same four workouts were used throughout the duration of the study alternating each week.

Body composition (4-compartment model), VO2peak, countermovement jump performance, muscle size and echo intensity (muscle quality) as well as strength and power of the knee extensors and plantar flexors were measured before and after training. Body composition testing was completing using dual-energy x-ray absorpiometry, air displacement plethysmogrphay, and bioeletrical impedance. VO2peak was measured using a standardized maximal exercise test on a treadmill. Countermovement jump height and power was recorded with participants performing jumps on a force plate. Muscle size and quality were determined using non-invasive ultrasonography. Finally, serum growth hormone responses to the VO2peak test were measured before and after the protocols.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two groups performed different types of high-intensity interval trainingTwo groups performed different types of high-intensity interval training
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Effects of Plyometric- and Cycle-Based High-Intensity Interval Training on Body Composition, Aerobic Capacity, and Muscle Function in Young Females: a Field-based Group Fitness Assessment
Actual Study Start Date :
Aug 1, 2018
Actual Primary Completion Date :
Nov 21, 2018
Actual Study Completion Date :
Nov 21, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Plyometric High-Intensity Interval Training

This group performed high-intensity interval training consisting of body-weight, plyometric exercises involving jumping.

Behavioral: High-Intensity Interval Training
The training intervention is a popular exercise format that consist of alternating brief bouts of high-intensity efforts with bouts of light effort or complete rest.

Experimental: Cycling High-Intensity Interval Training

This group performed high-intensity interval training consisting of cycling exercise.

Behavioral: High-Intensity Interval Training
The training intervention is a popular exercise format that consist of alternating brief bouts of high-intensity efforts with bouts of light effort or complete rest.

Outcome Measures

Primary Outcome Measures

  1. Maximal oxygen consumption at baseline [Pre-intervention]

    Standard measure of maximal oxygen consumption or peak aerobic capacity during exercise

  2. Maximal oxygen consumption after 8-week intervention [At week 9]

    Standard measure of maximal oxygen consumption or peak aerobic capacity during exercise

  3. Body fat percentage at baseline [Pre-intervention]

    Relative amount of body fat a person possesses

  4. Body fat percentage after 8-week intervention [At week 9]

    Relative amount of body fat a person possesses

  5. Fat-free mass at baseline [Pre-intervention]

    Amount of non-fat tissue a person possesses

  6. Fat-free mass after 8-week intervention [At week 9]

    Amount of non-fat tissue a person possesses

  7. Peak torque at baseline [Pre-intervention]

    Strength of a muscle

  8. Peak torque after 8-week intervention [At week 9]

    Strength of a muscle

  9. Muscle cross-sectional area at baseline [Pre-intervention]

    The size of a muscle

  10. Muscle cross-sectional area after 8-week intervention [At week 9]

    The size of a muscle

  11. Muscle composition at baseline [Pre-intervention]

    echo-intensity value derived from ultrasound that indicates the amount of fat infiltration in muscle

  12. Muscle composition after 8-week intervention [At week 9]

    echo-intensity value derived from ultrasound that indicates the amount of fat infiltration in muscle

  13. Muscle power at baseline [Pre-intervention]

    Product of torque and velocity as determined on a dynamometer

  14. Muscle power after 8-week intervention [At week 9]

    Product of torque and velocity as determined on a dynamometer

Secondary Outcome Measures

  1. Fat mass at baseline [Pre-intervention]

    Amount of fat tissue a person possesses

  2. Fat mass after 8-week intervention [At week 9]

    Amount of fat tissue a person possesses

  3. Peak heart during maximal testing at baseline [Pre-intervention]

    The highest heart rate attained during maximal exercise testing

  4. Peak heart during maximal testing after 8-week intervention [At week 9]

    The highest heart rate attained during maximal exercise testing

  5. Growth hormone response at baseline [Pre-intervention]

    The acute, exercise-induced response for growth hormone

  6. Growth hormone response after 8-week intervention [At week 9]

    The acute, exercise-induced response for growth hormone

  7. Countermovement jump height at baseline [Pre-intervention]

    Height of jump

  8. Countermovement jump height after 8-week intervention [At week 9]

    Height of jump

  9. Time to peak torque at baseline [Pre-intervention]

    How quickly muscle torque is generated

  10. Time to peak torque after 8-week intervention [At week 9]

    How quickly muscle torque is generated

Other Outcome Measures

  1. Weekly exercising heart rate [during 8-week exercise intervention]

    A descriptor of the exercise physiological intensity for both protocols

  2. Weekly exercising perceived effort [during 8-week exercise intervention]

    Perceived intensity derived from the rating of perceived exertion scale

  3. Calorie consumption at baseline [Pre-intervention]

    Amount of calories consumed at beginning and end of protocol

  4. Calorie consumption after 8-week intervention [At week 9]

    Amount of calories consumed at beginning and end of protocol

  5. Protein consumption at baseline [Pre-intervention]

    Amount of protein consumed at beginning and end of protocol

  6. Protein consumption after 8-week intervention [At week 9]

    Amount of protein consumed at beginning and end of protocol

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Between 18-35 years of age

  • Female

  • Currently participating in 2-4 days of structured exercise for 30-75 minutes for the last 6 months

Exclusion Criteria:
  • Currently participating in these exercise formats (2x/week within last 3 months)

  • Engaging in high intensity interval training for more than 30 min/week

  • Have diagnosed disorders/diseases in the following: cardiovascular, pulmonary, immunological, or metabolic

  • Current musculoskeletal injuries

  • Pregnant or think you may be pregnant

  • Currently taking any non-steroidal anti-inflammatory drug(s) or steroidal drug(s)

  • Currently a smoker or has consistently smoked within the last year

  • Has a positive written or verbal pre-study drug screen including alcohol (more than 7 drinks/week), THC/cannabinoids, amphetamines, benzodiazepines, cocaine, opioids, phencyclidine, barbiturates, cotinine.

  • Currently taking any medication that will significantly affect your heart rate response to exercise

  • If you miss four or more classes, you will be excluded from the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kennesaw State University Kennesaw Georgia United States 30144

Sponsors and Collaborators

  • Kennesaw State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Garrett Hester, Associate Professor of Exercise Science, Kennesaw State University
ClinicalTrials.gov Identifier:
NCT05821504
Other Study ID Numbers:
  • 2022-0465
First Posted:
Apr 20, 2023
Last Update Posted:
Apr 20, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 20, 2023